Tocagen
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Tocagen and buy or sell other stocks, ETFs, and their options commission-free!About TOCA
Tocagen, Inc. is a clinical-stage, cancer-selective gene therapy company, which engages in the development of product candidates designed to activate a patient's immune system against their own cancer. It is in the business of discovery, development, and commercialization of products for the treatment of cancer.
CEOMartin J. Duvall, MBA
CEOMartin J. Duvall, MBA
Employees14
Employees14
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2007
Founded2007
Employees14
Employees14
TOCA Key Statistics
Market cap424.93M
Market cap424.93M
Price-Earnings ratio-6.60
Price-Earnings ratio-6.60
Dividend yield—
Dividend yield—
Average volume225.20K
Average volume225.20K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$31.27
52 Week high$31.27
52 Week low$4.90
52 Week low$4.90
Stock Snapshot
With a market cap of 424.93M, Tocagen(TOCA) trades at $33.93. The stock has a price-to-earnings ratio of -6.60.
On 2025-12-22, Tocagen(TOCA) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 225.2K.
The stock's 52-week range extends from a low of $4.90 to a high of $31.27.
The stock's 52-week range extends from a low of $4.90 to a high of $31.27.
People also own
Based on the portfolios of people who own TOCA. This list is generated using Robinhood data, and it’s not a recommendation.